Get Latest Data
EuroPCR

LEARN ABOUT XIENCE AT 
EUROPCR MAY 16-19, 2017.

Visit the Abbott Booth

CLICK HERE

more

The Science Behind Xience Safety

Xience stent safety and performance

XIENCE's unparalleled safety1-3 and superior performance is due to its unique design and fluoropolymer coating, as well as the elution of everolimus.

more

The Science Behind Xience Safety

Xience stent safety and performance

XIENCE's unparalleled safety1-3 and superior performance is due to its unique design and fluoropolymer coating, as well as the elution of everolimus.

more

Xience Safety For Complex Patients

Xience stent thrombosis rate

Multiple recent XIENCE trial results, with endpoints ranging from 1 to 3 years,4-7 reveal excellent safety data on stent thrombosis (ST) in left main disease, diabetes and other complex conditions.

more

Xience Safety For Complex Patients

Xience stent thrombosis rate

Multiple recent XIENCE trial results, with endpoints ranging from 1 to 3 years,4-7 reveal excellent safety data on stent thrombosis (ST) in left main disease, diabetes and other complex conditions.

more

Experts' and Patient's point of view

To life-saving implants for patients

“I thought, ’How lucky am I, on top of everything else, to have had XIENCE to help me continue to live my life to the fullest?’ ”

Alec R., triathlete and
cyclist, patient treated for
chronic total occlusion (CTO)

Play video

To life-saving implants for patients

“I thought, ’How lucky am I, on top of everything else, to have had XIENCE to help me continue to live my life to the fullest?’ ”

Alec R., triathlete and
cyclist, patient treated for
chronic total occlusion (CTO)

Play video

From comparative testing of XIENCE
From comparative testing of XIENCE
To comparative clinical data
To comparative
clinical data
To life-saving implants for patients

“I thought, ’How lucky am I, on top of everything else, to have had XIENCE to help me continue to live my life to the fullest?’ ”

Alec R., triathlete and
cyclist, patient treated for
chronic total occlusion (CTO)

Play video

To life-saving implants for patients

“I thought, ’How lucky am I, on top of everything else, to have had XIENCE to help me continue to live my life to the fullest?’ ”

Alec R., triathlete and
cyclist, patient treated for
chronic total occlusion (CTO)

Play video

To live-saving implants for patients
To life-saving implants for patients

Get the Latest Data

Sign up to receive the latest about XIENCE study results, as they become available.
References
  1. Valgimigli M. Effects of cobalt-chromium everolimus eluting or bare metal stent on fatal and non-fatal cardiovascular events: a patient-level meta analysis. EuroPCR 2014.  
  2. Bangalore S, et al. BMJ. 2013;347:f6625. doi: 10.1136/bmj.f6625.
  3. Palmerini T, et al. JACC. 2014;63:299-307. doi: 10.1016/j.jacc.2013.09.061.
  4. Stone GW, et al. EXCEL Trial 3-year data. N Engl J Med. 2016;375:2223-2235. doi: 10.1056/NEJMoa1610227.
  5. Teeuwen K, et al. PRISON IV Trial 1-year data. JACC Cardiovasc Interv. 2016. doi: 10.1016/ j.jcin.2016.10.017.
  6. Kaul U. 2-Year TUXEDO Outcomes. TCT 2016.
  7. Lam, M. TWENTE Trial. Am Heart J.  2015;169:69-77. doi: 10.1016/j.ahj.2014.10.011. 
  8. Palmerini T, et al. Lancet. 2012:379:1393-1402.
Share site

Abbott Vascular International BVBA
Park Lane, Culliganlaan 2B, 1831 Diegem, Belgium, Tel: 32.2.714.14.11

Caution: This product is intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use provided inside the product carton (when available) or at eifu.abbottvascular.com for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. Information contained herein for distribution outside the U.S. only. Check the regulatory status of the device before distribution in areas where CE marking is not the regulation in force. Tests performed by and data on file at Abbott Vascular. Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott Vascular. XIENCE is a trademark of the Abbott Group of Companies. Promus Element, Promus Element Plus, Promus Premier and Synergy are trademarks of Boston Scientific Corporation or its affiliates. Resolute, Resolute Integrity and Resolute Onyx are trademarks of Medtronic, Inc. Nobori and Ultimaster are trademarks of Terumo Corporation. BioMatrix and BioMatrix Flex are trademarks of Biosensors International. Orsiro is a trademark of Biotronik SE & Co. KG.

©2017 Abbott. All rights reserved.

AP2944124-WBO Rev.A
Share site

You are about to leave the Abbott family of websites for a third party website.

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.

The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit the website?
YES NO

Disclaimer

Xiencestent.com is a product-specific website that is NOT intended for U.S. residents. This web content is exclusively reserved for health care professionals in countries with applicable health authority product registrations.

If you are a resident of a country other than those to which the site is directed, please contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.

Do you wish to continue to visit the International section of this website?

Accept Decline